Sickle Cell Disease Trial, Recruiting (NCT07392216)

Sickle Cell Disease Trial, Recruiting NCT07392216 Sponsor: St. Jude Children's Research Hospital Condition: Sickle Cell Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07392216 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sickle Cell Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have sickle cell disease (any type), OR you are a healthy sibling, relative, person living in the same household, or a female of similar racial/ethnic background to someone with sickle cell disease
You are between 10 and 18 years old at the time of joining the trial
You are female

Who may not be able to join:

You have previously had a stem cell transplant or gene therapy, or you are currently planning to have a stem cell transplant or gene therapy before the trial begins
You or your parent/legal guardian are unable or unwilling to sign a written consent form agreeing to take part
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christine Yu, MD, St. Jude Children's Research Hospital

Phone: 888-226-4343

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07392216

Sponsor: St. Jude Children's Research Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Sickle Cell Disease

Trial contact: 888-226-4343

More information: https://clinicaltrials.gov/study/NCT07392216

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have sickle cell disease (any type), OR you are a healthy sibling, relative, person living in the same household, or a female of similar racial/ethnic background to someone with sickle cell disease
You are between 10 and 18 years old at the time of joining the trial
You are female

Who may not be able to join:

You have previously had a stem cell transplant or gene therapy, or you are currently planning to have a stem cell transplant or gene therapy before the trial begins
You or your parent/legal guardian are unable or unwilling to sign a written consent form agreeing to take part
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

St. Jude Children's Research Hospital

Registry

ClinicalTrials.gov

Start date

2 June 2026

Est. completion

1 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Difference in AMH levels in pre-teens and adolescent females with SCD compared with healthy female controls (siblings, relatives, or non-relatives) at the same age; Difference in AMH levels in pre-teens and adolescent females with SCD compared with healthy female controls (siblings, relatives, or non-relatives) at the same pubertal stage

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov